Pharmacoflash / Posters Modérés (PM2) - Pharmacovigilance 2 (analytique)

• 113 • PM2-001 - Evolution of the spectrum of drugs associated with acute generalized exanthematous pustulosis over time: a pharmacovigilance study > T. Thomas Bettuzzi • 95 • PM2-002 - Drug-induced Depressive Symptoms: an update through the WHO pharmacovigilance database > F. François Montastruc • 5 • PM2-003 - Cardiovascular Adverse Effects of Oral Targeted Therapies in Chronic Lymphocytic Leukemia: A Case/Non-Case Study in VigiBase > Y. Yoann Zelmat • 213 • PM2-004 - Birth defects reporting and the use of dydrogesterone in assisted reproductive technology: a global pharmacovigilance study > A. Alexandra Henry • 241 • PM2-005 - Safety evaluation of live biotherapeutic products : systematic review of randomised controlled trials > B. Boris Lerais • 252 • PM2-006 - Outcome of statin rechallenge after atorvastatin-induced liver injury: an analysis from the French pharmacovigilance database > B. Blandine Bertin • 274 • PM2-007 - Propofol Infusion Syndrome: Analysis of French Pharmacovigilance and World Health Organization Pharmacovigilance (VigiBase®) Databases from 2020 to 2023 > N. Nathalie Massy